TCS at WDSC Americas 2023: Discussing Pharmacovigilance in the AI Era

TCS at the World Drug Safety Congress Americas 2023

One of the largest congregations of pharmacovigilance (PV) professionals worldwide, is expected to bring together more than 1,000 industry stakeholders in pharma to discuss the key challenges faced in PV and device safety.

TCS is a proud Diamond Sponsor of this event. Drop by our booth #701 to engage with our core PV leadership. Learn more about our deep PV transformation expertise and experience our purpose-built solution – TCS ADD™ Safety, an AI platform for pharmacovigilance.

TCS is part of multiple speaking sessions wherein speakers from the global top 10 pharma will join us and share insights during the TCS-hosted keynote panel. A track speaking session with the theme ‘Next Gen Tech & Data – New emerging tech in PV’ is also lined up.

Don’t miss out on these interesting discussions and POC story-sharing at the event!

Keynote panel discussion

Title: Pharmacovigilance in the era of AI

Date and time: Oct 18 | 9:40 AM ET to 10:20 AM ET

The TCS ADD™ Safety team will bring practical and theoretical guidelines on how to implement a pilot program, scale up, and achieve the most efficiency out of the AI-based PV platform. This platform has completed more than three years in the production environment. The team will interact on fundamental topics, challenges, opportunities, and next-gen technology applications to PV along with real-life examples.

Don’t miss the opportunity to engage with our experts in this one-on-one session.

Speakers – Keynote Panel

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD™ Safety Platform

Dr. Alejandra Guerchicoff holds a Ph.D. in Molecular Genetics. At TCS, she is an Industry Advisor for the Life Sciences, TCS ADD™ platform. She has 20 years of experience in clinical research and post-marketing PV. Currently, she works on the development of innovative technology solutions with AI across various life sciences operations.

Michael Murphy

Executive Director, Head Pharmacovigilance Operation

Michael D. Murphy leads the PV operations team at Global Patient Safety, Amgen. He oversees teams that are accountable for adverse event case processing and medical review, periodic reporting, oversight of safety technologies among other things. He has over 20 years of experience in pharma, focused on PV, with expertise in change management, process excellence, and safety systems.

Joann Evangelista

Head of US Patient Safety Operations & Innovations

Joann is the Head of US Patient Safety Operations & Innovations at Genentech, with over 20 years of experience in a federally regulated landscape holding multiple positions in the Commercial and Medical Affairs organizations. She is a revered visionary leader and integrated systems thinker whose journey with Artificial Intelligence started seven years ago when AI in AE detection was at the edge of its adoption. She has cultivated an environment rich in technology using innovative approaches with AI and machine learning to sustain PV operational excellence in a rapidly changing environment. Joann’s experiences and perspective have lent itself to assess multiple AI tools across high risk PV areas to decrease exposure and increase compliance and efficiency.

FIRESIDE CHAT

Title: Next Generation PV - A discussion of this new modality

Date and time: Oct 19 | 11:40 AM to 12:00 PM ET

The ever-increasing volume of safety reports can easily fail to handle adverse events timely, thus compromising the safety and health of patients and consumers.

During the last five years, we have seen rapid advancements and the adoption of cognitive technologies. AI-based PV platforms have progressed, however, there are concerns about the quality of information, accuracy with which these AI-ML platforms can interpret safety report data, justify decisions made by AI, and investments required for these new systems.

During this session, we will discuss how despite the challenges, the AI-based PV platforms are advancing.

Know more about TCS ADD™ Safety Platform here.

SPEAKERS - FIRESIDE CHAT

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD™ Safety Platform

Dr. Alejandra Guerchicoff holds a Ph.D. in Molecular Genetics. At TCS, she is an Industry Advisor for the Life Sciences, TCS ADD™ platform. She has 20 years of experience in clinical research and post-marketing PV. Currently, she works on the development of innovative technology solutions with AI across various life sciences operations. a.guerchicoff@tcs.com

Narayanan R

Chief Architect, Head of Clinical and Safety Platform

Narayanan heads the Clinical and Safety products of the TCS ADD™ platform. He works closely with multiple pharma and biotech companies to enable the adoption of digital products and solutions to transform their drug development processes and systems.

SESSION CHAIR

Title: AI and Machine Learning

Date and time: Oct 19 | 11:25 AM

SPEAKER

Karam Veer Singh (KV)

Head of Global Markets, Solutions & Partnerships

KV has been in the industry for 20+ years, with an international experience spanning across Consulting, Technology and Business functions. In his current role at Tata Consultancy Services, he responsible for driving growth and commercial strategy of TCS ADD™ suite of Platforms, focusing on Global Markets, Solutions & Partnerships for Life Sciences & Healthcare Industries.

SESSION CHAIR

Title: Next-gen tech & Data

Date and time: Oct 19 | 11:25 AM

SPEAKER

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD™ Safety Platform

Dr. Alejandra Guerchicoff holds a Ph.D. in Molecular Genetics. At TCS, she is an Industry Advisor for the Life Sciences, TCS ADD™ platform. She has 20 years of experience in clinical research and post-marketing PV. Currently, she works on the development of innovative technology solutions with AI across various life sciences operations. a.guerchicoff@tcs.com

Where adaptability meets advantage

With you for the long run

Our Thought Leadership Institute

Want to be a global change-maker? Join our team.

Find the latest news about TCS in our Newsroom

Recent Press releases

Recent News

Recent recognitions

Upcoming events

TCS works hand in hand with world-leading investors.

Global knowledge. Local support

Industry

Solution

TCS at the World Drug Safety Congress Americas 2023

Keynote panel discussion

Speakers – Keynote Panel

Dr. Alejandra Guerchicoff

Michael Murphy

Joann Evangelista

FIRESIDE CHAT

SPEAKERS - FIRESIDE CHAT

Dr. Alejandra Guerchicoff

Narayanan R

SESSION CHAIR

SPEAKER

Karam Veer Singh (KV)

SESSION CHAIR

SPEAKER

Dr. Alejandra Guerchicoff

Related reading

Transformation starts here

Find out more